芪蛭益肾胶囊 | China Drugs ListQizhi Yishen capsules | China Drugs List

本页为公开参考信息,不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。

药品类型
中成药Traditional Chinese medicine
治疗领域
肾脏疾病Kidney diseases
公开来源记录的适应症
益气养阴,化瘀通络。用于早期糖尿病肾病气阴两虚证,症见倦怠乏力、口干咽燥、五心烦热、食少纳呆、面色无华、肢体麻木。舌质淡,或舌质暗红或有瘀斑、瘀点,或少苔;脉细或细涩。In TCM, replenishes qi and nourishes yin, disperses blood stasis and unblocks the channels. For early diabetic nephropathy with deficiency of both qi and yin. Manifestations include fatigue and weakness, dry mouth and throat, heat in the palms, soles and chest, poor appetite, a dull complexion, numbness of the limbs, a pale or dark-red tongue or a tongue with ecchymoses, petechiae or scant coating, and a fine or fine-choppy pulse.
适应症来源与口径
来源日期: 2024, 2026. 适应症转录自国家医保局公开的企业申报资料;不代表已核实完整的现行说明书。Source date(s): 2024, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
说明书信息局限
适应症已与官方公开申报资料核对。尚未取得完整原始说明书。Indications checked against an official public submission. The full original prescribing information is still unavailable.
中国可获得性状态
已核实中国历史批准记录;尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
海外状态
待逐一核查各市场。Market-by-market verification pending.
医保分类
已纳入国家医保(乙类)Included in national insurance (Category B)
医保版本
2025版;2026年1月1日起执行2025 edition; effective 1 January 2026
医保限制
该目录条目未另列限定;仍须遵守目录凡例及法定适应症No additional restriction is specified for this NRDL entry; the general NRDL rules and legally approved indications still apply.
医保期限
2025-01-01 至 2026-12-312025-01-01 to 2026-12-31
医保核查说明
按成分/剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

来源

打开交互详情、公开价格与讨论